- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT04445974
Testing a Body-functionality Intervention for Body Image in Individuals With Skin Conditions
Can a Brief Body-functionality Writing Intervention Improve Body Image in Individuals Living With a Skin Condition? A Randomised Control Trial
Aperçu de l'étude
Statut
Intervention / Traitement
Description détaillée
Method of sampling/recruitment:
Recruitment from community sample, including: The University staff and student volunteers lists; Psychology undergraduate credit systems, Social media/forums; Charities; Research recruitment platforms, and a mailing lists.
Sample size:
An apriori power analysis, based on an ANCOVA, with a medium effect for the primary outcome (body appreciation) indicated a sample of 128 would be needed to achieve 80% power. Assuming an attrition rate of 50%, the total number of participants required will be 256.
In line with recommendations for evaluating interventions, we will include an internal pilot whereby we review the recruitment progress (completion) about 3 months into the trial and could then consider whether we need to make any minor or major adjustments to the recruitment strategy or study. If these substantial changes are needed, the pilot component will be written up and analysed separately to inform the next phase.
Procedure:
Time-point 1: Participants asked to read information sheet and provide consent. Participants will then be asked to complete the demographic measures and provide information on their skin condition(s). Participants will then complete baseline measures of trait body appreciation, body functionality, and, skin-specific quality of life, appearance anxiety with the order of these questionnaires counterbalanced. The online system will then randomly allocate individual meeting the exclusion criteria to either 'Expand Your Horizon' or an active control, at a ratio of 1:1. Participants will then be asked to complete the first writing activity and complete state measures
Time-point 2 (approximately 2 days later): Participants asked to complete the second writing exercise, and rate their state measures.
Time-point 3 (approximately 1 week later): Participants will be asked to complete the final writing task, before completing state measures and repeating the outcome measures given at baseline. Participants in both conditions will then be asked to provide feedback on the intervention.
Time-point 4 (One month later): Participants will be asked to repeat the outcome measures. Participants will then be shown the debrief screen and told which group they were in. Participants in the control condition will be offered a link to the intervention.
Analytic strategy:
The data will be initially assessed to check whether they meet the assumptions of the statistical tests used.
Descriptive statistics will then be used to describe the sample, and to summarise information on attrition at each point of the study and feedback on the intervention. Demographic and skin disease-history variables will be assessed for covariance using t-tests, ANOVAs and bivariate correlations as appropriate.
To assess whether randomisation of allocation to groups (intervention vs control) has been effective, t-tests and ANOVAs will be used, as appropriate, to compare demographics baseline measures.
T-tests will also be used to compare the levels of skin-specific appearance satisfaction, appearance satisfaction and body-functionality satisfaction between participants in both the intervention and control condition. This will include both intention-to-treat and completer analyses.
The effectiveness of the intervention will be tested using a series of between group ANCOVAs.
The number of participants showing reliable and clinical change on measures of anxiety and skin-specific quality of life will also be calculated for each group.
Change over time (Pre, post, one month follow up) for each group will be assessed using a repeated measures ANOVA. If any significant covariates, are identified ANCOVAs will be used instead.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Choose Province
-
Sheffield, Choose Province, Royaume-Uni, S1 2LT
- Department of Psychology, University of Sheffield
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Individuals with dermatological condition (including conditions that affect the skin, hair and/or nails). This includes, but is not limited to, acne, eczema, alopecia, psoriasis, vitiligo, rosacea, dermatitis, hyperpigmentation, hidradenitis suppurativa (HS), hyperhidrosis, hirsutism, neurofibromatosis, onychomycosis, melasma, cysts, herpes, ichthyosis, and lichen sclerosus.
- Individuals self-reporting that their body image is affected by their skin condition.
- Sufficient English to complete the measures and writing exercises
- Access to the internet.
Exclusion Criteria:
- As the focus of this research is on skin disease, individuals living with visible differences as a consequence of trauma (e.g. scarring from burns or scarring from traumatic injury) are not eligible to participate in this study.
- Individuals who do not feel their body image is affected by having a dermatological condition.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Expand Your Horizons: More than my skin
Participants allocated to the intervention condition will be asked to follow the adapted instructions for 'Expand Your Horizon'.
Participants will be asked to complete three 15 min writing exercises over approximately six days.
Participants who complete the first exercise on Qualtrics will be sent links to and asked to complete the second and third writing exercises.
|
'Expand Your Horizon' is a self-help intervention which uses writing exercises to help individuals with poor body image practice focusing on their body-functionality rather than their physical appearance (Alleva et al., 2015).
The materials for 'Expand Your Horizon' are freely available (Alleva et al., 2015), and permission has been granted to use and adapt the materials in this research.
'Expand Your Horizon' comprises of three 15 min writing exercises, typically completed over approximately six days.
The intervention materials have been adapted for use with a population with skin diseases, and modified to use gender neutral language.
Adaptions were made in consultation with experts by experience.
The changes were reviewed and approved by the first author of the original intervention to ensure the materials were in keeping with the original intervention.
|
|
Expérimental: Control writing activity
Participants in the control condition will be asked to complete three 15 minute creative writing exercises online via Qualtucs over approximately six days.
Participants completing the first writing exercise will be sent links to the second and third writing exercises.
|
In line with previous studies examining 'Expand Your Horizon' the active control condition will involve creative writing tasks (Alleva et al., 2015).
Participants in the intervention condition will complete three 15 minute creative writing exercises, completed over six days.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in body appreciation
Délai: Baseline to 1 week
|
The Body Appreciation Scale 2 (BAS-2, Tylka & Wood-Barcalow, 2015) will be used to measure body appreciation and contains 10 items, and will be used to measure trait levels of body appreciation.
Each item is rated on a scale of 1 (never) to 5 (always).
The average score is calculated by adding each item and divided by 10, and can range between 1 and 5 with higher numbers indicating higher levels of body appreciation.
|
Baseline to 1 week
|
|
Change in body functionality appreciation
Délai: Baseline to 1 week
|
The Functionality Appreciation Scale (FAS: Alleva, Tylka, & Van Diest, 2017) will be used to measure body functionality appreciation.
The FAS comprises of seven questions, and will be used to assess participants' trait levels of appreciation for their bodies' functionality (Appendix L).
Each item is rated on a scale from 1 (strongly disagree) to 5 (strongly agree).
The average score is calculated by adding each item and dividing by 7, and can range between 1 and 5 with higher numbers indicating higher levels of function appreciation.
|
Baseline to 1 week
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in dermatology specific quality of life
Délai: Baseline to 1 week
|
The Dermatology Quality of Life Index (DLQI: Finlay & Khan, 1994) will be used to measure the impact of skin-conditions on participants' quality of life (Appendix M).
The DLQI contains 10 questions scored from 0 (not at all/not relevant) to 3 (very much).
Total scores range from 0 to 30, with lower scores indicating greater skin-specific quality of life.
|
Baseline to 1 week
|
|
Change in dermatology specific quality of life at follow up
Délai: Baseline to 1 month
|
The Dermatology Quality of Life Index (DLQI: Finlay & Khan, 1994) will be used to measure the impact of skin-conditions on participants' quality of life (Appendix M).
The DLQI contains 10 questions scored from 0 (not at all/not relevant) to 3 (very much).
Total scores range from 0 to 30, with lower scores indicating greater skin-specific quality of life.
|
Baseline to 1 month
|
|
Chance in skin-specific shame
Délai: Baseline to 1 week
|
The Skin Shame Scale (SSS: Scott, 2004) will be used to measure levels of skin-specific shame.
The SSS contains 24 items, which are rated on a scale from 1 (never) to 5 (always).
Total scores can range from 24 to 120, with higher score indicating greater levels of shame.
|
Baseline to 1 week
|
|
Chance in skin-specific shame at follow up
Délai: Baseline to 1 month
|
The Skin Shame Scale (SSS: Scott, 2004) will be used to measure levels of skin-specific shame.
The SSS contains 24 items, which are rated on a scale from 1 (never) to 5 (always).
Total scores can range from 24 to 120, with higher score indicating greater levels of shame.
|
Baseline to 1 month
|
|
Change in appearance anxiety
Délai: Baseline to 1 week
|
The Appearance Anxiety Index (AAI: Veale et al., 2014) will be used to measure appearance anxiety.
The AAI contains 10 questions focused on cognitive and behavioural components of appearance-related anxiety, including avoidance and threat monitoring.
Each item is scored on a five point Likert scale from 0 (not at all) to 4 (all the time).
Total scores can range from 0 to 40, with higher scores indicating a greater level of appearance-related anxiety.
|
Baseline to 1 week
|
|
Change in appearance anxiety at follow up
Délai: Baseline to 1 month
|
The Appearance Anxiety Index (AAI: Veale et al., 2014) will be used to measure appearance anxiety.
The AAI contains 10 questions focused on cognitive and behavioural components of appearance-related anxiety, including avoidance and threat monitoring.
Each item is scored on a five point Likert scale from 0 (not at all) to 4 (all the time).
Total scores can range from 0 to 40, with higher scores indicating a greater level of appearance-related anxiety.
|
Baseline to 1 month
|
|
State appearance satisfaction
Délai: Day 1
|
After writing exercise 1, participants will also be asked to rate their state satisfaction with their appearance on a 100 point visual analogue scale (100 = extremely satisfied and 0 = extremely dissatisfied).
|
Day 1
|
|
State appearance satisfaction
Délai: Day 3 (approximately)
|
After writing exercise 2, participants will also be asked to rate their state satisfaction with their appearance on a 100 point visual analogue scale (100 = extremely satisfied and 0 = extremely dissatisfied).
|
Day 3 (approximately)
|
|
State appearance satisfaction
Délai: 1 week
|
After writing exercise 3, participants will also be asked to rate their state satisfaction with their appearance on a 100 point visual analogue scale (100 = extremely satisfied and 0 = extremely dissatisfied).
|
1 week
|
|
State skin appearance satisfaction
Délai: Day 1
|
After writing task 1, participants will also be asked to rate their satisfaction with their state skin appearance on a 100 point visual analogue scale (100 = extremely satisfied and 0 = extremely dissatisfied).
|
Day 1
|
|
State skin appearance satisfaction
Délai: Day 3 (approximately)
|
After writing task 2, participants will also be asked to rate their satisfaction with their state skin appearance on a 100 point visual analogue scale (100 = extremely satisfied and 0 = extremely dissatisfied).
|
Day 3 (approximately)
|
|
State skin appearance satisfaction
Délai: 1 week
|
After writing task 3, participants will also be asked to rate their satisfaction with their state skin appearance on a 100 point visual analogue scale (100 = extremely satisfied and 0 = extremely dissatisfied).
|
1 week
|
|
State functionality satisfaction
Délai: Day 1
|
After writing task 1, participants will also be asked to rate their state satisfaction with their body functionality on a 100 point visual analogue scale (100 = extremely satisfied and 0 = extremely dissatisfied).
|
Day 1
|
|
State functionality satisfaction
Délai: Day 3 (approximately)
|
After writing task 2, participants will also be asked to rate their state satisfaction with their body functionality on a 100 point visual analogue scale (100 = extremely satisfied and 0 = extremely dissatisfied).
|
Day 3 (approximately)
|
|
State functionality satisfaction
Délai: 1 week
|
After writing task 3, participants will also be asked to rate their state satisfaction with their body functionality on a 100 point visual analogue scale (100 = extremely satisfied and 0 = extremely dissatisfied).
|
1 week
|
|
Change in body appreciation at follow up
Délai: Baseline to 1 month
|
The Body Appreciation Scale 2 (BAS-2, Tylka & Wood-Barcalow, 2015) will be used to measure body appreciation and contains 10 items, and will be used to measure trait levels of body appreciation.
Each item is rated on a scale of 1 (never) to 5 (always).
The average score is calculated by adding each item and divided by 10, and can range between 1 and 5 with higher numbers indicating higher levels of body appreciation.
|
Baseline to 1 month
|
|
Change in body functionality appreciation at follow up
Délai: Baseline to 1 month
|
The Functionality Appreciation Scale (FAS: Alleva, Tylka, & Van Diest, 2017) will be used to measure body functionality appreciation.
The FAS comprises of seven questions, and will be used to assess participants' trait levels of appreciation for their bodies' functionality (Appendix L).
Each item is rated on a scale from 1 (strongly disagree) to 5 (strongly agree).
The average score is calculated by adding each item and dividing by 7, and can range between 1 and 5 with higher numbers indicating higher levels of function appreciation.
|
Baseline to 1 month
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Intervention evaluation
Délai: 1 week
|
Participants in the functionality intervention will be asked to complete a series of questions about their experience of the intervention, and given the option to add any further comments in a free text box.
|
1 week
|
|
Adherence
Délai: Through study completion (on average 1 week)
|
Adherence will be assessed by reviewing the content of participants writing and time-spent on the exercises and word count. Participant entries will also be rated, on a three-point scale, whether the content of participants writing conforms to the given instructions; if there is no relevant content, it will be scored 0, if instructions are partially followed, it will score 1, and if instruction are fully followed it will score a 2. to identify inappropriate responses. Previous studies evaluating the intervention have reported minimal information about how adherence was assessed. |
Through study completion (on average 1 week)
|
|
Attrition
Délai: Through study completion (on average 1 week)
|
The number of participants that drop out across the study
|
Through study completion (on average 1 week)
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Paul G Overton, PhD, University of Sheffield
Publications et liens utiles
Publications générales
- Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994 May;19(3):210-6. doi: 10.1111/j.1365-2230.1994.tb01167.x.
- Tylka TL, Wood-Barcalow NL. The Body Appreciation Scale-2: item refinement and psychometric evaluation. Body Image. 2015 Jan;12:53-67. doi: 10.1016/j.bodyim.2014.09.006. Epub 2014 Oct 21.
- Alleva JM, Martijn C, Van Breukelen GJ, Jansen A, Karos K. Expand Your Horizon: A programme that improves body image and reduces self-objectification by training women to focus on body functionality. Body Image. 2015 Sep;15:81-9. doi: 10.1016/j.bodyim.2015.07.001. Epub 2015 Aug 14.
- Alleva JM, Tylka TL, Kroon Van Diest AM. The Functionality Appreciation Scale (FAS): Development and psychometric evaluation in U.S. community women and men. Body Image. 2017 Dec;23:28-44. doi: 10.1016/j.bodyim.2017.07.008. Epub 2017 Aug 17.
- Scott, C. (2004). Understanding psychodermatological distress: constructing a skin shame scale (Doctoral dissertation, University of Sheffield, UK). Retrieved from http://etheses.whiterose.ac.uk/14863/1/412462.pdf
- Veale D, Eshkevari E, Kanakam N, Ellison N, Costa A, Werner T. The Appearance Anxiety Inventory: validation of a process measure in the treatment of body dysmorphic disorder. Behav Cogn Psychother. 2014 Sep;42(5):605-16. doi: 10.1017/S1352465813000556. Epub 2013 Jul 3.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 165478
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Qualité de vie
-
Nordsjaellands HospitalHvidovre University Hospital; Nordstar MedicalPas encore de recrutementAffection primaire : Bloc nerveux | Condition secondaire : Déplacement du cathéter | Focus of Study: Nerf SciatiqueDanemark
-
Queens College, The City University of New YorkRecrutementPublication d'articles soumis à l'American Journal of Public HealthÉtats-Unis
-
Abramson Cancer Center of the University of PennsylvaniaRetiréPatients cancéreux subissant une greffe de cellules souches (RCT of ACP for Transplant)
-
Emel YürükPas encore de recrutementIntervention mERAS | Le score ASA (American Society of Anesthesiologists) | Le patient doit avoir entre 4 et 12 ans
-
Swansea UniversityComplétéA Bite of ACT '(BOA) Cours de psychoéducation en ligne sur la thérapie d'acceptation et d'engagement | Un contrôle de liste d'attenteRoyaume-Uni
-
Yale-NUS CollegeComplétéL'objectif de l'étude est les réponses des patients à un questionnaire de gestion de l'obésité administré par le SGH Life CenterSingapour
-
Zonguldak Bulent Ecevit UniversityComplétéGroupes à risque I-II de l'American Society of Anesthesiologists (ASA) | la Phase Folliculaire (Jours 1-12 Après les Dernières Menstruations) ou Lutéale (Jours 20-24) du Cycle Menstruel | Âgé de 18 à 55 ansTurquie (Türkiye)
-
Central Hospital, Nancy, FranceInstitut National de la Santé Et de la Recherche Médicale, FranceComplétéInflammation | Maladies du système nerveux autonome | Choc, cardiogénique | Extra-Corporeal-Life-Support (ECLS)France
-
Yale-NUS CollegeComplétéL'objectif de l'étude est les réponses des patients à un questionnaire de gestion de l'obésité administré par le SGH Life CenterSingapour
-
Icahn School of Medicine at Mount SinaiChildren's Hospital of PhiladelphiaRecrutement